These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17094135)

  • 1. Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity.
    Zastre J; Jackson JK; Wong W; Burt HM
    J Pharm Sci; 2007 Apr; 96(4):864-75. PubMed ID: 17094135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers.
    Zastre J; Jackson J; Burt H
    Pharm Res; 2004 Aug; 21(8):1489-97. PubMed ID: 15359586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers.
    Zastre J; Jackson J; Bajwa M; Liggins R; Iqbal F; Burt H
    Eur J Pharm Biopharm; 2002 Nov; 54(3):299-309. PubMed ID: 12445560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
    Elamanchili P; McEachern C; Burt H
    J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity.
    Zastre JA; Jackson JK; Wong W; Burt HM
    Mol Pharm; 2008; 5(4):643-53. PubMed ID: 18380467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.
    Li W; Li X; Gao Y; Zhou Y; Ma S; Zhao Y; Li J; Liu Y; Wang X; Yin D
    Mol Pharm; 2014 Jan; 11(1):71-80. PubMed ID: 24256068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
    Collnot EM; Baldes C; Wempe MF; Kappl R; Hüttermann J; Hyatt JA; Edgar KJ; Schaefer UF; Lehr CM
    Mol Pharm; 2007; 4(3):465-74. PubMed ID: 17367162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.
    Vilas-Boas V; Silva R; Nunes C; Reis S; Ferreira L; Vieira C; Carvalho F; Bastos Mde L; Remião F
    Toxicol Lett; 2013 Jul; 220(3):259-66. PubMed ID: 23685082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities.
    Orlowski S; Selosse MA; Boudon C; Micoud C; Mir LM; Belehradek J; Garrigos M
    Cancer Biochem Biophys; 1998 Jun; 16(1-2):85-110. PubMed ID: 9923970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation.
    Khamenehfar A; Wan CP; Li PC; Letchford K; Burt HM
    Anal Bioanal Chem; 2014 Nov; 406(28):7071-83. PubMed ID: 25315452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
    Rege BD; Kao JP; Polli JE
    Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
    Letchford K; Liggins R; Wasan KM; Burt H
    Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.
    Hugger ED; Novak BL; Burton PS; Audus KL; Borchardt RT
    J Pharm Sci; 2002 Sep; 91(9):1991-2002. PubMed ID: 12210046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy.
    Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK
    Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations.
    Letchford K; Liggins R; Burt H
    J Pharm Sci; 2008 Mar; 97(3):1179-90. PubMed ID: 17683080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
    Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
    J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.
    Hugger ED; Audus KL; Borchardt RT
    J Pharm Sci; 2002 Sep; 91(9):1980-90. PubMed ID: 12210045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of monoglycerides on P-glycoprotein: modulation of the activity and expression in Caco-2 cell monolayers.
    Barta CA; Sachs-Barrable K; Feng F; Wasan KM
    Mol Pharm; 2008; 5(5):863-75. PubMed ID: 18651749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
    Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
    Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.